AU2005216651A1 - Treatment of interstitial cystitis with vitamin D compounds - Google Patents

Treatment of interstitial cystitis with vitamin D compounds Download PDF

Info

Publication number
AU2005216651A1
AU2005216651A1 AU2005216651A AU2005216651A AU2005216651A1 AU 2005216651 A1 AU2005216651 A1 AU 2005216651A1 AU 2005216651 A AU2005216651 A AU 2005216651A AU 2005216651 A AU2005216651 A AU 2005216651A AU 2005216651 A1 AU2005216651 A1 AU 2005216651A1
Authority
AU
Australia
Prior art keywords
compound
vitamin
methyl
mmol
hexane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005216651A
Other languages
English (en)
Inventor
Enrico Colli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioxell SpA
Original Assignee
Bioxell SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0404567A external-priority patent/GB0404567D0/en
Priority claimed from GB0404571A external-priority patent/GB0404571D0/en
Priority claimed from PCT/US2004/031532 external-priority patent/WO2005030223A1/en
Application filed by Bioxell SpA filed Critical Bioxell SpA
Publication of AU2005216651A1 publication Critical patent/AU2005216651A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2005216651A 2004-03-01 2005-03-01 Treatment of interstitial cystitis with vitamin D compounds Abandoned AU2005216651A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0404567A GB0404567D0 (en) 2004-03-01 2004-03-01 Methods for treating bladder dysfunction and related compounds and compositions
GB0404567.0 2004-03-01
GB0404571.2 2004-03-01
GB0404571A GB0404571D0 (en) 2004-03-01 2004-03-01 Methods for treating interstitial cystitis and related compounds and compositions
AUPCT/US2004/031532 2004-09-24
PCT/US2004/031532 WO2005030223A1 (en) 2003-09-24 2004-09-24 Methods for treating bladder dysfunction
PCT/EP2005/050902 WO2005082375A2 (en) 2004-03-01 2005-03-01 Treatment of interstitial cystitis with vitamin d compounds

Publications (1)

Publication Number Publication Date
AU2005216651A1 true AU2005216651A1 (en) 2005-09-09

Family

ID=34915952

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005216651A Abandoned AU2005216651A1 (en) 2004-03-01 2005-03-01 Treatment of interstitial cystitis with vitamin D compounds

Country Status (7)

Country Link
US (1) US20080039434A1 (enExample)
EP (1) EP1737468A2 (enExample)
JP (1) JP2007525533A (enExample)
AU (1) AU2005216651A1 (enExample)
BR (1) BRPI0508333A (enExample)
CA (1) CA2557809A1 (enExample)
WO (1) WO2005082375A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2580962A1 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
RU2423972C1 (ru) * 2009-12-16 2011-07-20 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Способ консервативного лечения гиперактивного мочевого пузыря у детей с учетом его суточной активности
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
US9877929B2 (en) 2011-10-13 2018-01-30 Premier Dental Products Company Topical vitamin D and ubiquinol oral supplement compositions
US9724542B2 (en) 2012-10-12 2017-08-08 Premier Dental Products Company Remineralizing and desensitizing compositions, treatments and methods of manufacture
US9877930B2 (en) 2012-10-12 2018-01-30 Premier Dental Products Company Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
CA2886067C (en) * 2012-10-12 2021-04-06 Premier Dental Products Company Topical vitamin d oral supplement compositions
CN104758300A (zh) * 2014-01-02 2015-07-08 上海泽生科技开发有限公司 维生素d及其组合物的抗菌用途
RU2602954C1 (ru) * 2015-07-27 2016-11-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения хронических воспалительных заболеваний уретры и мочевого пузыря
WO2017147420A1 (en) * 2016-02-25 2017-08-31 The University Of Florida Research Foundation, Inc. Methods and compositions with vitamin d compounds for treatment of cystic fibrosis and respiratory disorders
CN111885435B (zh) 2016-11-23 2025-04-11 华为技术有限公司 无源光网络系统、光线路终端及光网络单元

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639596A (en) 1969-07-14 1972-02-01 Wisconsin Alumni Res Found Method of treating leg weakness in fowl with 25-hydroxycholecalciferol
US3739001A (en) 1971-10-22 1973-06-12 Wisconsin Alumni Res Found 25,26-dihydroxycholecalciferol
US3741996A (en) 1971-12-02 1973-06-26 Wisconsin Alumni Res Found 1{60 -hydroxycholecalciferol
US3715374A (en) 1972-05-05 1973-02-06 Wisconsin Alumni Res Found 24,25-dihydroxycholecalciferol
US3847955A (en) 1973-07-16 1974-11-12 Wisconsin Alumni Res Found 1,24,25-trihydroxycholecalciferol
JPS5126858A (en) 1974-08-22 1976-03-05 Teijin Ltd 24 * s * hidorokishikorekarushifuerooruno seizoho
JPS5126859A (en) 1974-08-22 1976-03-05 Teijin Ltd 24 * r * hidorokishikorekarushifuerooruno seizoho
JPS5271456A (en) 1975-12-12 1977-06-14 Chugai Pharmaceut Co Ltd Synthesis of 1alpha-hydroxysteroid derivatives
US4717721A (en) 1985-05-30 1988-01-05 Howard W. Bremer Sidechain homo-vitamin D compounds with preferential anti-cancer activity
US4927815A (en) * 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
US4847012A (en) 1988-04-29 1989-07-11 Wisconsin Alumni Research Foundation Vitamin D related compounds and processes for their preparation
US4851401A (en) 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
US5312328A (en) * 1991-01-11 1994-05-17 Baxter International Inc. Ultra-sound catheter for removing obstructions from tubular anatomical structures such as blood vessels
US20050090553A1 (en) * 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
CA2096105A1 (en) 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5428029A (en) 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
JP3372259B2 (ja) 1995-09-21 2003-01-27 ウィスコンシン・アルムニ・リサーチ・ファウンデーション カルシトリオール誘導体およびそれらの用途
SG70009A1 (en) 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
US6030962A (en) 1997-04-28 2000-02-29 Synttex (U.S.A.) Inc. Vitamin D3 analogs with bis C-20 side chains
WO1998049138A2 (en) 1997-04-28 1998-11-05 F.Hoffmann-La Roche Ag Vitamin d3 analogs with bis c-20 side chains
FR2763328B1 (fr) 1997-05-14 1999-07-02 Vetrotex France Sa Procede de production de fils de verre ensimes et produits resultants
US6017908A (en) 1997-05-16 2000-01-25 Women And Infants Hospital 3-EPI vitamin D2 compounds and uses thereof
EP0981523B1 (en) 1997-05-16 2005-12-07 Woman & Infants Hospital Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof
WO2001040177A2 (en) 1999-12-02 2001-06-07 Women And Infants Hospital Esters of vitamin d3 and uses thereof
US20010034328A1 (en) * 2000-02-25 2001-10-25 Cartt Stephen Lahue Treatment of male chronic pelvic pain syndrome
WO2004098612A2 (en) * 2003-05-07 2004-11-18 Ab Science Calcitriol analogs of uses thereof
BRPI0414701A (pt) * 2003-09-24 2006-11-14 Bioxell Spa uso de um composto de vitamina d, método de prevenção ou tratamnento de disfunção de bexiga em um paciente, composto de vitamina d, e, kit

Also Published As

Publication number Publication date
WO2005082375A2 (en) 2005-09-09
EP1737468A2 (en) 2007-01-03
BRPI0508333A (pt) 2007-07-17
CA2557809A1 (en) 2005-09-09
US20080039434A1 (en) 2008-02-14
WO2005082375A3 (en) 2005-10-13
JP2007525533A (ja) 2007-09-06

Similar Documents

Publication Publication Date Title
AU2005216651A1 (en) Treatment of interstitial cystitis with vitamin D compounds
BRPI0609666A2 (pt) uso de um composto de vitamina d, método para prevenir e /ou tratar endometriose, formulação farmacêutica, composto de vitamina d, e, kit
WO2011088209A2 (en) 1-deoxy analogs of vitamin d-related compounds
AU2004275845A1 (en) Methods for treating bladder dysfunction
JP4512490B2 (ja) ビタミンｄ類似体、該類似体を含んで成る組成物およびその使用
CA2601545A1 (en) Use of vitamin d compounds to treat endometriosis
ZA200606720B (en) Treatment of interstitial cystitis with vitamin D compounds
JP2002543062A (ja) ビタミンｄ類似体およびその薬学的使用
AU2005303773A1 (en) Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer
ZA200602097B (en) Methods for treating bladder dysfunction
WO2006035075A1 (en) Use of vitamin d compounds for the prevention or treatment of chronic prostatitis
JP2005503434A (ja) ３−デスオキシ−ビタミンｄ３類似体
US20090298799A1 (en) Methods of Treating Osteoporosis and Secondary Hyperparathyroidism Using 20-Methyl, Gemini Vitamin D3 Compounds
US20100093675A1 (en) Novel method
JP4361528B2 (ja) ビタミンｄ３ラクトン誘導体
US20100009949A1 (en) Novel method
AU2007306292A1 (en) Novel method of treatment of male sub-fertility

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period